Bio-Path Holdings, Inc.
Income Statement
| Line Item | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Dec 2016 | Sep 2016 | Jun 2016 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.0K | $0 | $0 | $0 | $13.0K | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $1.4M | $1.6M | $1.5M | $1.0M | $954.0K | $2.3M | $1.2M | $1.0M |
| SG&A Expense | $815.0K | $893.0K | $845.0K | $970.0K | $727.0K | $681.0K | $757.0K | $849.0K |
| Operating Income | $-2.2M | $-2.5M | $-2.3M | $-2.0M | $-1.7M | $-3.0M | $-1.9M | $-1.9M |
| Operating Margin | -5,862.2% | — | — | — | -12,830.8% | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-2.2M | $-2.5M | $-2.0M | $-397.0K | $-1.4M | $-1.6M | $-1.9M | $-1.9M |
| Net Margin | -5,856.8% | — | — | — | -10,546.2% | — | — | — |
| EPS (Basic) | $-3.08 | $-0.05 | $-0.06 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $-3.08 | $-0.05 | $-0.06 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 56.7M | 500.3M | 500.3M | 478.2M | 478.2M | 478.2M | 448.8M | 448.8M |
| Shares Outstanding (Diluted) | 56.7M | 500.3M | 500.3M | 478.2M | 478.2M | 478.2M | 448.8M | 448.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |